Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00207610 · ClinicalTrials.gov registry record · Phase 3
Iron Supplementation Among Low-Income Postpartum Women
A Phase 3 study, sponsored by Centers for Disease Control and Prevention.
- Completed
- Registry status
- Phase 3
- Development phase
- 959
- Enrollment target
NCT00207610 is a Phase 3 study that has completed, run by Centers for Disease Control and Prevention. The registered enrollment target is 959 participants.
The verdict
NCT00207610, a Phase 3 study, has completed, sponsored by Centers for Disease Control and Prevention.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 959 participants
- Enrollment target
Study Summary
Anemia is common among low-income women after they have given birth. Anemia, or low hemoglobin in the blood cells, is usually caused by not having enough iron. Blood cells usually carry oxygen to other parts of the body. Without enough hemoglobin, the ability of blood cells to carry oxygen is decreased. Memory and work may be impaired. The purpose of this study is to evaluate three methods of giving iron to prevent anemia among low-income women after they have given birth.
Interventions
- BEHAVIORAL Daily iron supplements of 65 mg a day for 3 months
- BEHAVIORAL Universal anemia screening and treatment
- BEHAVIORAL Selective anemia screening and treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 959 participants |
| Start Date | 2003-06 |
| Est. Completion | 2007-09 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00207610
The ClinicalTrials.gov registry entry for NCT00207610 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 959 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Centers for Disease Control and Prevention, which has 139 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Daily iron supplements of 65 mg a day for 3 months is the first listed.
NCT00207610 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00207610 about?
NCT00207610 is a clinical study titled "Iron Supplementation Among Low-Income Postpartum Women". Anemia is common among low-income women after they have given birth. Anemia, or low hemoglobin in the blood cells, is usually caused by not having enough iron. Blood cells usually carry oxygen to other parts of the body. Without enough hemoglobin, the ability of blood cells to carry oxygen is decrea...
What is the current status of trial NCT00207610?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 959 participants. The study started on 2003-06. Estimated completion is 2007-09.
What interventions are being tested in trial NCT00207610?
The interventions under investigation include: Daily iron supplements of 65 mg a day for 3 months (BEHAVIORAL), Universal anemia screening and treatment (BEHAVIORAL), Selective anemia screening and treatment (BEHAVIORAL).
Who is sponsoring clinical trial NCT00207610?
This trial is sponsored by Centers for Disease Control and Prevention, which has 139 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.